Rick Klausner is the founder and chief scientist of Altos Labs and founder and chairman of Lyell Immunopharma, Inc. He is also president of the Milky Way Research Foundation, founder and managing partner of Milky Way Investments, and chairman of Sonoma Biotherapeutics. Klausner founded and directed Juno Therapeutics and GRAIL and was co-founder and chairman of Lifemine Therapeutics. Previously, he was senior vice president, chief medical officer, and chief opportunity officer of Illumina Corporation and executive director for global health of the Bill and Melinda Gates Foundation. Klausner served as director of the U.S. National Cancer Institute between 1995 and 2001 and was chief of the Cell Biology and Metabolism Branch of the National Institute of Child Health and Human Development. He is a past president of the American Society of Clinical Investigation.
Previously
When Franklin D. Roosevelt signed legislation giving birth to the National Cancer Institute (NCI) in 1937, he brought a decade of political wrangling to a close and created th...